Decreasing plasma soluble IL-1 receptor antagonist and increasing monocyte activation early post-transplant may be involved in pathogenesis of delayed graft function in renal transplant recipients.
about
Differentially expressed RNA from public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions.Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplantDecreased circulating and neutrophil mediated VEGF-A165 release in stable long-term cardiac transplant recipients
P2860
Decreasing plasma soluble IL-1 receptor antagonist and increasing monocyte activation early post-transplant may be involved in pathogenesis of delayed graft function in renal transplant recipients.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Decreasing plasma soluble IL-1 ...... n renal transplant recipients.
@ast
Decreasing plasma soluble IL-1 ...... n renal transplant recipients.
@en
Decreasing plasma soluble IL-1 ...... n renal transplant recipients.
@nl
type
label
Decreasing plasma soluble IL-1 ...... n renal transplant recipients.
@ast
Decreasing plasma soluble IL-1 ...... n renal transplant recipients.
@en
Decreasing plasma soluble IL-1 ...... n renal transplant recipients.
@nl
prefLabel
Decreasing plasma soluble IL-1 ...... n renal transplant recipients.
@ast
Decreasing plasma soluble IL-1 ...... n renal transplant recipients.
@en
Decreasing plasma soluble IL-1 ...... n renal transplant recipients.
@nl
P2093
P1476
Decreasing plasma soluble IL-1 ...... n renal transplant recipients.
@en
P2093
Cord Naujokat
Jan Schmidt
Mahmoud Sadeghi
Martin Zeier
Volker Daniel
P304
P356
10.1111/J.1399-0012.2009.01130.X
P577
2009-11-18T00:00:00Z